207 related articles for article (PubMed ID: 34593593)
1. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
[TBL] [Abstract][Full Text] [Related]
2. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
[TBL] [Abstract][Full Text] [Related]
3. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
[TBL] [Abstract][Full Text] [Related]
4. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head intra-individual comparison of total-body 2-[
Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
[TBL] [Abstract][Full Text] [Related]
6. Ultralow-dose [
Tan H; Qi C; Cao Y; Cai D; Mao W; Yu H; Sui X; Liu G; Shi H
Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of total-body
Hu Y; Liu G; Yu H; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3538-3546. PubMed ID: 35344063
[TBL] [Abstract][Full Text] [Related]
8. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
Alberts I; Sachpekidis C; Prenosil G; Viscione M; Bohn KP; Mingels C; Shi K; Ashar-Oromieh A; Rominger A
Ann Nucl Med; 2021 Apr; 35(4):485-492. PubMed ID: 33550515
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Image Quality and Activity Optimization in Oncologic
van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
[TBL] [Abstract][Full Text] [Related]
11. Image quality and lesion detectability in low-dose pediatric
Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
[TBL] [Abstract][Full Text] [Related]
12. Application of the long axial field-of-view PET/CT with low-dose [
Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI.
Behr SC; Bahroos E; Hawkins RA; Nardo L; Ravanfar V; Capbarat EV; Seo Y
Mol Imaging Biol; 2018 Jun; 20(3):492-500. PubMed ID: 29192363
[TBL] [Abstract][Full Text] [Related]
15. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
16. Total-body
Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
[TBL] [Abstract][Full Text] [Related]
17. Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by
Xiao J; Yu H; Sui X; Hu Y; Cao Y; Liu G; Zhang Y; Hu P; Wang Y; Li C; Xu B; Shi H
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):269-278. PubMed ID: 34185138
[TBL] [Abstract][Full Text] [Related]
18. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.
Alberts I; Hünermund JN; Prenosil G; Mingels C; Bohn KP; Viscione M; Sari H; Vollnberg B; Shi K; Afshar-Oromieh A; Rominger A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2395-2404. PubMed ID: 33797596
[TBL] [Abstract][Full Text] [Related]
19. A personal acquisition time regimen of
Xiao J; Yu H; Sui X; Liu G; Cao Y; Yanzhao Z; Zhang Y; Hu P; Cheng D; Shi H
Cancer Imaging; 2022 Dec; 22(1):78. PubMed ID: 36578034
[TBL] [Abstract][Full Text] [Related]
20. The image quality, lesion detectability, and acquisition time of
Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
